Northwest Biotherapeutics Inc

Northwest Biotherapeutics Inc

NWBO

Market Cap$374.82M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Northwest Biotherapeutics IncNorthwest Biotherapeutics Inc-4.2-100%--0.8
$-0.12

Current Fair Value

147.5% downside

Overvalued by 147.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$374.82 Million
Enterprise Value$441.05 Million
Dividend Yield$0 (0%)
Earnings per Share$-0.07
Beta-1.09
Outstanding Shares1,359,496,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-4.15
PEG-58.71
Price to Sales-
Price to Book Ratio-0.26
Enterprise Value to Revenue299.42
Enterprise Value to EBIT-5.86
Enterprise Value to Net Income-6
Total Debt to Enterprise0.16
Debt to Equity-0.81

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Northwest Biotherapeutics Inc

CEO: Linda Powers